Pharma group Krka's net profit up 42% to EUR 172m in first nine months
Ljubljana, 21 November - The Novo Mesto-based pharmaceutical group, Krka, generated EUR 1.09 billion in sales revenue in the first nine months of the year, which is 12% more than in the same period last year. Net profit increased by 42% to EUR 171.9 million. Sales were up in all regions and most markets.
The rest of this news item is available to subscribers.
The news item consists of 1.697 characters (without spaces) or 356 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.